GO TO CMA Home
GO TO Inside CMA
GO TO Advocacy and Communications
GO TO Member Services
GO TO Publications
GO TO Professional Development
GO TO Clinical Resources

GO TO What's New
GO TO Contact CMA
GO TO Web Site Search
GO TO Web Site Map


JPN

Official Journal of the Canadian College of Neuropsychopharmacology
Revue officielle du College canadien de neuropsychopharmacologie

March 1999 / mars 1999

J Psychiatry Neurosci 1999;24(2)

© 1999 Canadian Medical Association / Association médicale canadienne


Do you have a question about managing pharmacological treatment for patients with psychiatric and neurological disorders? See: Psychopharmacology for the Clinician, made possible by an unrestricted educational grant from Wyeth-Ayerst Canada Inc.

Avez-vous des questions sur la gestion du traitement pharmacologique des patients atteints de troubles psychiatriques et neurologiques? Voir : Psychopharmacologie clinique, parrainée par une subvention à l'éducation non restreinte de Wyeth-Ayerst Canada Inc..


  Editorial · Éditorial
95 Understanding autism — a work in progress P.E. Tanguay [full text]
 
  Commentary · Commentaire
97 Transcranial magnetic stimulation: using a law of physics to treat psychopathology G.M. Hasey [full text]
 
  Review Papers · Examens critiques
103 Etiology of infantile autism: a review of recent advances in genetic and neurobiological research G. Trottier, L. Srivastava, C.-D. Walker [full text / résumé]
116 Assessing the machinery of mind: synapses in neuropsychiatric disorders W.G. Honer [abstract / résumé]
 
  Research Papers · Articles de recherche
122 Discriminative stimulus properties of indorenate, a serotonin agonist D.N. Velázquez-Martinez, M. López Cabrera, H. Sánchez, J.I. Ramírez, E. Hong [abstract / résumé]
131 Computed tomographic findings in schizophrenia: relation with symptom dimensions and sex differences A.K. Malla, J. Takhar, R.M.G. Norman, L. Assis [abstract / résumé]
 
Special section: Pharmacogenics · Section spéciale sur la pharmacogénétique
 
  Editorial · Éditorial
139 Pharmacogenetic research: a revolutionary science W. Kalow [full text]
 
  Research Paper · Article de recherche
141 T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability R. Joober, C. Benkelfat, K. Brisebois, A. Toulouse, G. Turecki, S. Lal, D. Bloom, A. Labelle, P. Lalonde, D. Fortin, M. Alda, R. Palmour, G.A. Rouleau [abstract / résumé]
 
  Review Papers · Examens critiques
147 Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease J. Poirier [abstract / résumé]
154 Pharmacogenetics of lithium response in bipolar disorder M. Alda [abstract / résumé]
159 Heterogeneity and the genetics of autism P. Szatmari [abstract / résumé]
 
166 Book Reviews · Recensions
192 Psychopharmacology for the Clinician · Psychopharmacologie pratique